ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
60,814.11
-1.61%
S&P 500
5,477.90
0.16%
Dow Jones
39,127.80
0.04%
US Dollar vs Yen
160.7955
0.69%
Brent Oil
84.435
0.30%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Shuttle Pharmaceuticals Holdings Inc (SHPH)

  7. Shuttle Pharmaceuticals Holdings Inc (SHPH) ニュース

SHPH

Shuttle Pharmaceuticals (SHPH)

Shuttle Pharmaceuticals Holdings Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:SHPH
日付受信時刻ニュースソース見出しコード企業名
2024/06/1822 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2024/06/1822 : 00GlobeNewswire Inc.Shuttle Pharma Appoints Timothy Lorber as Chief Financial OfficerNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2024/06/1019 : 12Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2024/05/2305 : 15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2024/05/2305 : 15GlobeNewswire Inc.Shuttle Pharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024NASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2024/05/1422 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2024/05/1422 : 00GlobeNewswire Inc.Shuttle Pharma Provides First Quarter 2024 Corporate UpdateNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2024/05/1406 : 01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2024/04/2405 : 15GlobeNewswire Inc.Shuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024NASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2024/03/2222 : 00PR Newswire (US)Shuttle Pharma Provides Fourth Quarter 2023 Corporate UpdateNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2024/03/0908 : 18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2024/03/0523 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2024/02/1322 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2024/02/1322 : 00PR Newswire (US)Shuttle Pharma Announces Its Intent to Pursue a Rights OfferingNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2024/02/0606 : 25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2024/01/2406 : 30PR Newswire (US)Shuttle Pharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024NASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2024/01/0823 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2024/01/0823 : 00PR Newswire (US)Shuttle Pharmaceuticals Receives FDA Approval to Proceed with Phase II Clinical Trial of Ropidoxuridine for Treatment of Patients with GlioblastomaNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2024/01/0307 : 10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2023/12/2111 : 51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2023/12/2007 : 10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2023/12/1123 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2023/12/1123 : 00PR Newswire (US)Shuttle Pharmaceuticals Submits IND Application to the U.S. FDA for Ropidoxuridine Phase II Clinical Trial for Patients with GlioblastomaNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2023/11/3023 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2023/11/1423 : 00PR Newswire (US)Shuttle Pharmaceuticals Provides Third Quarter 2023 Corporate UpdateNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2023/11/1406 : 21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2023/10/3122 : 00PR Newswire (US)Shuttle Pharma Advances Prostate Cancer Predictive Biomarker Program Through Exclusive License AgreementNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2023/10/3106 : 14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2023/10/2105 : 15Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
2023/10/2105 : 10Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:SHPH

最近閲覧した銘柄

NYSE
CVX
Chevron
FX
USDJPY
US Dollar vs Yen
FX
USDGBP
US Dollar vs Sterling
CCOM
SILVER
SILVER
COIN
ETHUSD
Ethereum
NYSE
DIS
Walt Disney
NASDAQ
MSFT
Microsoft
NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
SPY
SPDR S&P 500
USI
USTECH100
US Tech 100
CCOM
US500
US 500
USOTC
DTEGY
Deutsche Telekom (QX)
USOTC
ADDYY
Adidas (QX)
NYSE
MRK
Merck
NYSE
AXP
American Express
NYSE
BAC
Bank of America
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有